169 related articles for article (PubMed ID: 10595265)
1. Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II Demonstration Project.
Steel M; Smyth E; Vasen H; Eccles D; Evans G; Møller P; Hodgson S; Stoppa-Lyonnet D; Chang-Claude J; Caligo M; Morrison P; Haites N
Dis Markers; 1999 Oct; 15(1-3):125-31. PubMed ID: 10595265
[TBL] [Abstract][Full Text] [Related]
2. Costs and benefits of diagnosing familial breast cancer.
Heimdal K; Maehle L; Møller P
Dis Markers; 1999 Oct; 15(1-3):167-73. PubMed ID: 10595273
[TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
4. Genetic testing for familial breast cancer--ethical questions concerning individual rights and social responsibility.
Graumann S
Dis Markers; 1999 Oct; 15(1-3):136-8. PubMed ID: 10595267
[No Abstract] [Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
6. Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.
Chang-Claude J; Becher H; Caligo M; Eccles D; Evans G; Haites N; Hodgson S; Møller P; Weber BH; Stoppa-Lyonnet D
Dis Markers; 1999 Oct; 15(1-3):53-65. PubMed ID: 10595253
[TBL] [Abstract][Full Text] [Related]
7. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
8. Genetic testing.
Petersen GM
Hematol Oncol Clin North Am; 2000 Aug; 14(4):939-52. PubMed ID: 10949782
[TBL] [Abstract][Full Text] [Related]
9. Cancer genetics service provision: a comparison of seven European centres.
Hopwood P; van Asperen CJ; Borreani G; Bourret P; Decruyenaere M; Dishon S; Eisinger F; Evans DG; Evers-Kiebooms G; Gangeri L; Hagoel L; Legius E; Nippert I; Rennert G; Schlegelberger B; Sevilla C; Sobol H; Tibben A; Welkenhuysen M; Julian-Reynier C
Community Genet; 2003; 6(4):192-205. PubMed ID: 15331865
[TBL] [Abstract][Full Text] [Related]
10. Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe.
Morrison PJ; Steel CM; Vasen HF; Eccles D; Evans DG; Møller P; Hodgson S; Stoppa-Lyonnet D; Chang-Claude J; Caligo M; Olah E; Haites NE; Nevin NC
Dis Markers; 1999 Oct; 15(1-3):159-65. PubMed ID: 10595272
[No Abstract] [Full Text] [Related]
11. Ethical implications of genetic testing for breast cancer susceptibility.
Surbone A
Crit Rev Oncol Hematol; 2001 Nov; 40(2):149-57. PubMed ID: 11682322
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial aspects of familial breast and ovarian cancer: psychological guidelines for genetic testing.
Decruyenaere M; Evers-Kiebooms G; Claes E; Denayer L; Welkenhuysen M; Legius E; Demyttenaere K
Dis Markers; 1999 Oct; 15(1-3):152-3. PubMed ID: 10595271
[No Abstract] [Full Text] [Related]
13. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
14. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
15. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
16. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
Dickens BM; Pei N; Taylor KM
CMAJ; 1996 Mar; 154(6):813-8. PubMed ID: 8634959
[TBL] [Abstract][Full Text] [Related]
17. The Double Helix: Applying an Ethic of Care to the Duty to Warn Genetic Relatives of Genetic Information.
Weaver M
Bioethics; 2016 Mar; 30(3):181-7. PubMed ID: 26194147
[TBL] [Abstract][Full Text] [Related]
18. Patients' Attitudes Towards Disclosure of Genetic Test Results to Family Members: The Impact of Patients' Sociodemographic Background and Counseling Experience.
Gilbar R; Shalev S; Spiegel R; Pras E; Berkenstadt M; Sagi M; Ben-Yehuda A; Mor P; Perry S; Zaccai TF; Borochowitz Z; Barnoy S
J Genet Couns; 2016 Apr; 25(2):314-24. PubMed ID: 26371363
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
